Development of a Subcutaneous Fixed-Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose-Finding Study
Kirschbrown, Whitney P., Wynne, Chris, Kågedal, Matts, Wada, Russ, Li, Hanbin, Wang, Bei, Nijem, Ihsan, Badovinac Crnjevic, Tanja, Gasser, Helena, Heeson, Sarah, Eng-Wong, Jennifer, Garg, AmitМова:
english
Журнал:
The Journal of Clinical Pharmacology
DOI:
10.1002/jcph.1362
Date:
December, 2018
Файл:
PDF, 1.07 MB
english, 2018
File converter
Більше результатів пошуку
More benefits 
